My Cancer Portal y MCP Steering Group Jan 2016
|
|
|
- Nathaniel Owen
- 5 years ago
- Views:
Transcription
1 My Cancer Portal
2 Transforming Care After Treatment -TCAT Increased survivorship of patients with cancer Survivorship comes with a legacy Investment into detecting cancer early (DCE) Better treatments High initial investment We can improve the care of patients who have received treatment.
3 My Cancer Portal A single resource for patients and carers Co designed with patients Quality, safety and effectiveness at its core Sponsored by Macmillan Hosted by NHS Highland Collaboration of NHS/OpenBrolly/Macmillan /M Delivery April 2017 Chief Angus Watson
4 Consultation ti & Design Jan 2016 Patient & Staff panels June 2016 Beta testing July 2016 Full testing December 2016
5 My Cancer Portal Healthcare view MDT Form Treatment Summary Clinical l Dashboard HNA Form Electronic Patient Record SCIstore/Docman Patient Post or E Comms My Symptoms My Information & contact Links to other form web pages My Story Reflective writing My Cancer Portaland other media Pti Patient tview
6 Highlands & Western Isles Colorectal Cancer MDT Clients Name: Address: Responsible Consultant Dare of Birth CHI Number: GP: Practice: Current MDT Date Previous MDT Date Bowel Screening Presentation & Symptoms: Significant PMH: Specific Questions for MDT: Staging Site of Tumour Colonoscopy Adenomata CT Chest Liver Comments For rectal cancer MRI Circumferential Margin: Neoadjuvant Therapy Comments MDT Advice:
7 Surgery Liver: Peritoneum Operation performed & operative findings: Pathology T N M Nodes Involved/Sampled: Deepest level vascular Invasion: Polyp Cancer: Genetic Testing Grade: R Kikuchi SM level: Haggit level: MDT Discusssion Final Clinicopathological stage: T N M Prognosis
8 Follow Up Oncology Radiotherapy Chemotherapy Comments: Luminal surveillance: Time period: Imaging: MDT Process Complete? Clinical trial eligible? Comments P Reg: Patient Communication When:..Will speak with patient Yours sincerely Consultant GMC CONSULTANT GENERAL AND COLORECTAL SURGEON Chair and minute secretary for the MDT of the day
9 My Cancer Portal Holistic Needs Assessment Concerns checklist Living with and beyond cancer identifying your concerns Completed dby: Date: Designation Contact details: Patients Name Address CHI number This self assessment is optional, however it will help us understand the concerns and feelings you have. It will also help us identify any information and support you may need in the future. If any of the problems below have caused you concern in the past week and if you wish to discuss them with a health care professional, please tick the box. Leave the box blank if it doesn t apply to you or you don t want to discuss it now. I have questions about my diagnosis/treatment that I would like to discuss Physical concerns Practical concerns Spiritual or religious concerns Breathing difficulties Passing urine Constipation Diarrhoea Eating or appetite Indigestion Sore or dry mouth Caring responsibilities Work and education Money or housing Insurance and travel Transport or parking Contact/communication with NHS staff Loss of faith or other spiritual concern Loss of meaning or purpose of life Not being at peace with or feeling regret about the past Lifestyle or information needs Nausea or vomiting Sleep problems/nightmares Tired/exhausted or fatigued Swollen tummy or limb High temperature or fever Getting around (walking) Tingling in hands/feet Pain Hot flushes/sweating Dry, itchy or sore skin Wound care after surgery Memory or concentration Taste/Sight/hearing Speech problems My appearance Sexuality Housework or shopping Washing and dressing Preparing meals/drinks Family/relationship concerns Partner Children Other relatives/friends Emotional concerns Difficulty making plans Loss of interest/activities Unable to express feelings Anger or frustration Guilt Hopelessness Loneliness or isolation Sadness or depression Worry, fear or anxiety Support groups Complementary therapies Diet and nutrition Exercise and activity Smoking Alcohol or drugs Sun protection Hobbies Other Please mark the scale to show the overall level of concern you ve felt over the past week.
10 AW1 Patient Name Address Responsible Consultant Hospital Health Board/TRUST CHI number/nhs number Date of birth GP Name and address Tumour Site AW2 Diagnosis AW3 Cancer stage (TNM) Date of diagnosis Metastatic disease AW4 Treatment Aim AW5 Treatment completed? Appropriate for Primary Care to add to their palliative care register? AW6 AW9 Key symptoms which may require referral to specialist team: AW7 Other services currently involved Has patient been given a copy of this treatment t t summary? Summary of treatment AW8 Treatment type Completion Date Comments AW10 AW11 AW12
11 Slide 10 AW1 AW2 AW3 AW4 AW5 AW6 AW7 AW8 AW9 AW10 AW11 AW12 AW13 AW14 AW15 Demographics including patient name. CHI number. Address. GP. GP number and date of birth all pulled from PMS/SCIstore and will populate all the forms Need to decide how we log on to the whole system. Currently we log onto Formstream and we are presented with the landing page and sign in box. Suggest we keep this system and add the HNA and Treatment summary as forms that you scroll onto after the MDT form? Drop down list available on Formstream. Pre-populate from MDT form? Data available from Formstream. Staging/Site of tumour Drop down menu for all tumour types (or import directly from MDT Formstream) Currently not included in MDT Formstream. I think it should and will discuss with Jim Docherty data directly from MDT Formstream drop down. Yes/No/Uncertain Data from MDT Discussionin Formstream 'Prognosis' which is a drop down of Palliative/Curative drop down. Yes/No Data from Follow Up section in MDT form 'P-Reg' (drop down of yes/no) Free text box Free text box drop down 'yes/no' Mixture of drop down and free text. Drop down in Treatment type to include: surgery/neo adjuvant chemo-radiotherapy/ Neo adjuvant chemotherapy/ Adjuvant radiotherapy/ Adjuvant chemotherapy/ Palliative chemotherapy/ Palliative radiotherapy/ Hormonal therapy/ Immunotherapy. Completion date should be Date box to click on
12 Patient name/ CHI AW16 Possible treatment toxicities and / or late effects Required GP actions (in addition to GP Cancer Care Review) AW17 Medication prescribed from Secondary Care Secondary Care ongoing management plan Additional information including issues relating to lifestyle and support needs AW18 Referred to Macmillan Money Matters Team? Is DS1500 application applicable? Has DS 1500 been completed? Summary of information given to the patient about their cancer and future progress AW19 AW20 Name of health care professional Date AW21
13 Slide 11 AW16 AW17 AW18 AW19 AW20 AW21 AW22 AW23 AW24 pre-populate from SCI/PMS Free text box Free text box Free text box Free text box Not sure if we should leave this as a free text box for a healthcare worker to fill in. or automatically take data from the HNA boxes that have been ticked. Probably the former as an HNA may not be completed each time there is a treatment summary produced. all 'yes/no' drop down Free text Drop down box including all those with log ins for the system. Date taken from date box...or default to the date that form is accessed?
14
15
16 My Cancer Portal - engagement Patient Panels Initial stage x 2 Feb/March rd panel End of Beta testing Staff Panels Initial stage x 1 Beta testing x 1 Larger test x 1 30 patient testing group 1 further panel
17 Questions?
Chemotherapy Questions and Concerns: General information about what to expect
Chemotherapy Questions and Concerns: General information about what to expect Princess Margaret For patients who will get chemotherapy and their families Class Overview: What is chemotherapy Side effects
Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number:
Your Health Survey Why this questionnaire You may already have heard about renal units introducing health questionnaires. The purpose of these questionnaires is to find out how your kidney disease affects
Useful Self Assessment tools to help identify your needs and how you are feeling for patients and their family/caregivers
Useful Self Assessment tools to help identify your needs and how you are feeling for patients and their family/caregivers 114 115 Needs Assessment Tool Patients & Families [NAT-P&F] The topics below are
Supportive Care Audit NEMICS Region
Supportive Care Audit 2013-2014 NEMICS Region Melissa Shand Service Improvement Facilitator NEMICS November 2015 Acknowledgments Mandy Byrne NEMICS Cancer and Data Information Analyst Page 2 of 32 Table
A practical guide to living with and after cancer. Planning your care and support. Front cover
A practical guide to living with and after cancer Planning your care and support Front cover 1 Holistic Needs Assessment About this leaflet Being diagnosed with cancer can affect many areas of your life.
Supportive Care Audit Mercy Hospital for Women - Heidelberg
Supportive Care Audit 2013-2014 Mercy Hospital for Women - Heidelberg Melissa Shand Service Improvement Facilitator NEMICS July 2015 Acknowledgments Mandy Byrne NEMICS Cancer and Data Information Analyst
Beyond Cancer Moving On
Beyond Cancer Moving On Today, people with cancer have a better chance at living a normal life than ever before in history. In fact, there are more than 10 million survivors people who have, or are living
Pancreatic Cancer Action Patient and Carer Survey 2015
Pancreatic Cancer Action Patient and Carer Survey 2015 The survey was conducted online using Survey Monkey between 17 th August and 16 th October 2015 190 respondents made up of: Men: 56% Women: 44% Carers:
Personal organiser. This organiser is for anyone with secondary breast cancer. It is part of the Secondary breast cancer information pack.
Personal organiser This organiser is for anyone with secondary breast cancer. It is part of the Secondary breast cancer information pack. This information is by Breast Cancer Care. We are the only specialist
Palliative Care Asking the questions that matter to me
Palliative Care Asking the questions that matter to me THE PALLIATIVE HUB Adult This booklet has been developed by the Palliative Care Senior Nurses Network and adapted with permission from Palliative
National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce
National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce Duleep Allirajah Head of Policy, Macmillan Cancer Support Total Prevalence - now Total
Skull Base Tumour Service. The Multi-Disciplinary Team (MDT) Explained. Jan 2018 v1
Skull Base Tumour Service The Multi-Disciplinary Team (MDT) Explained Jan 2018 v1 Skull base tumours grow in the bones of the skull that form the bottom of the head and the body ridge between the nose
THE ACCEPTANCE AND IMPLEMENTATION OF INTERNATIONAL FRAMEWORKS THAT DO NOT REFLECT UPON THE AUSTRALIAN CONTEXT.
Is It Blind Faith? THE ACCEPTANCE AND IMPLEMENTATION OF INTERNATIONAL FRAMEWORKS THAT DO NOT REFLECT UPON THE AUSTRALIAN CONTEXT. Prepared By: Mark Brown (Social Worker - RNSH) Betsy Sajish (Senior Social
Other doctors to receive copies of records : Chief complaint / history of present illness (Describe why you have been referred here):
Patient Name: Date: Age: Date of Birth: Preferred Name: Preferred Language: Address: City: State: Zip: Phone: Cell Phone: Preferred Phone: Emergency Contact: Relationship: Email: If you would like to opt
Patient guide to Capecitabine chemotherapy with radiotherapy for rectal cancer
Patient Name: Patient guide to chemotherapy with radiotherapy for rectal cancer Chemotherapy This guide should only be given to patients who have been prescribed capecitabine chemotherapy in conjunction
Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team
NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN Cancer Survivorship Resources and Tools for the Multidisciplinary Team Your survivorship care plan is a summary of your tumor treatments and recommendations for
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: BEP (5 day) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Nintedanib-Docetaxel PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.
Afatinib (Giotrif) Afatinib (Giotrif ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Bevacizumab + Chemotherapy PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
UW MEDICINE PATIENT EDUCATION. Baby Blues and More DRAFT. Knowing About This in Advance Can Help
UW MEDICINE PATIENT EDUCATION Baby Blues and More Recognizing and coping with postpartum mood disorders Some women have baby blues or more serious postpartum mood disorders. It helps to know about these
Recovering at home. How will I feel when I get home? How should I look after my wound?
How will I feel when I get home? Following your operation it is normal to have feelings of stress, anxiety or depression. Being affected emotionally is normal. It may help to talk about how you feel with
Michael Connors Director of Services
Michael Connors Director of Services 34 years helping people to live well with the impact of cancer Understanding the patient experience Penny Brohn Whole Person Model Mind Emotions WHOLE PERSON AFFECTED
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine- Carboplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
Survivorship Guidelines. September 2013 (updated August 2015)
Survivorship Guidelines September 2013 (updated August 2015) CONTENTS Contents 1 Introduction... 3 2 Background... 3 3 Recommendations and Rationale... 4 Appendix 1: Holistic Needs Assessment... 9 Appendix
UW MEDICINE PATIENT EDUCATION. Baby Blues and More. Postpartum mood disorders DRAFT. Emotional Changes After Giving Birth
UW MEDICINE PATIENT EDUCATION Baby Blues and More Postpartum mood disorders Some new mothers have baby blues or more serious postpartum mood disorders. This chapter gives ideas for things you can do to
were here to help Macmillan Cancer Information and Support Centre Wexham Park Hospital, Slough
were here to help Macmillan Cancer Information and Support Centre Wexham Park Hospital, Slough If you ve been diagnosed with cancer, you can use this booklet to request information In partnership with
Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...
![Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...](/thumbs/85/92602023.jpg "Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...")
Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -
Guide for. Gynecologic. Cancer. Survivors. foundationforwomenscancer.org
Guide for Gynecologic Cancer Survivors foundationforwomenscancer.org I'm a survivor a living example of what people can go through and survive. ~ ELIZABETH TAYLOR The Foundation for Women s Cancer is committed
Nivolumab. Nivolumab
Nivolumab Nivolumab This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people immunotherapy may reduce the risk of the cancer coming back, for
Gynae Cancer Multi Disciplinary Team Patient Information
Gynae Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with gynaecological cancers which include cancer of the cervix, ovary, vulva, vagina
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Everolimus PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Niraparib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Survivorship: Life Beyond Cancer Treatment
Survivorship: Life Beyond Cancer Treatment 1 1 Dear Cancer Survivor, The Cancer Survivorship program at University of Maryland St. Joseph Medical Center s Cancer Institute is designed to help patients
Ibrutinib (Imbruvica )
Ibrutinib (Imbruvica) Ibrutinib (Imbruvica ) This leaflet is offered as a guide to you and your family. Ibrutinib is a type of anti-cancer treatment called a targeted therapy. The aim of this treatment
A practical guide to living with and after cancer. Helping you take an active role in your cancer care
A practical guide to living with and after cancer Helping you take an active role in your cancer care About this leaflet About this leaflet 2 This leaflet is about how you can take an active role in your
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Carboplatin-Etoposide PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cisplatin- Capecitabine- Trastuzumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
Wellness along the Cancer Journey: Palliative Care Revised October 2015
Wellness along the Cancer Journey: Palliative Care Revised October 2015 Chapter 2: Palliative Care Palliative Care Rev. 10.8.15 Page 352 Group Discussion True False Not Sure 1. Palliative care is only
The organs and tissues of the body are made up of tiny building blocks called cells. Cancer is a disease of these cells.
Surgery: English Surgery This fact sheet is about surgery for cancer. This is when someone has an operation to remove part of the body where the cancer is growing. It is also used to help diagnose cancer.
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Irinotecan- Capecitabine (CAPIRI) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
University College Hospital. Finishing radiotherapy treatment. Radiotherapy Department Patient information series
University College Hospital Finishing radiotherapy treatment Radiotherapy Department Patient information series 17 2 If you need a large print, audio or translated copy of the document, please contact
Contents Introduction Context nationally and locally What is a health and wellbeing event?... 4
Living With and Beyond Cancer Merseyside and Cheshire Health and Wellbeing Clinic Event Guidance January 2017 Contents 1 1. Introduction... 2 2. Context nationally and locally... 3 3. What is a health
Breast Cancer Multi Disciplinary Team Patient Information
Breast Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with breast cancer. It tells you about the breast multidisciplinary team and other
Myeloma Haematology and Transplant Unit
BCD Myeloma Haematology and Transplant Unit BCD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.
Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,
Abemaciclib (Verzenios ) Abemaciclib (Verzenios )
Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib is a targeted (biological) therapy. This group of drugs block the growth and spread of cancer. They target and interfere with processes in
CANCER REHABILITATION PATHWAY - HAEMATOLOGY
CANCER REHABILITATION PATHWAY - HAEMATOLOGY Statement: To be used in conjunction with Brain and CNS Rehabilitation Care Pathway as appropriate Diagnosis and Care Planning: The following symptom pathways
Improving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
Capecitabine chemotherapy and concurrent radiotherapy to the pancreas
Capecitabine chemotherapy and concurrent radiotherapy to the pancreas Capecitabine chemotherapy and concurrent radiotherapy to the pancreas This leaflet is offered as a guide to you and your family. You
Ceritinib (Zykadia )
(Ceritinib (Zykadia ) (Xalkori) Ceritinib (Zykadia ) This leaflet is offered as a guide to you and your family. Ceritinib (Zykadia ) is a type of anti-cancer treatment called a targeted therapy. The aim
Myeloma Haematology and Transplant Unit CTD1
CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names.
Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
Erlotinib (Tarceva )
Erlotinib (Tarceva ) Erlotinib (Tarceva ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB. Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital
This is a repository copy of Health-related quality of life after treatment for bladder cancer in England.
This is a repository copy of Health-related quality of life after treatment for bladder cancer in England. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/130368/ Version:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Ponatinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Stereotactic ablative radiotherapy (SABR) to the spine
The Clatterbridge Cancer Centre NHS Foundation Trust Stereotactic ablative radiotherapy (SABR) to the spine Radiotherapy A guide for patients and carers This information is for patients who are going to
University College Hospital
University College Hospital Holistic Needs Assessment (HNA) Information for patients, relatives and carers About this leaflet Having a diagnosis of cancer can affect you and your quality of life in many
National Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Oxaliplatin- Fluorouracil (FOLFOX) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
IT IS YOUR RESPONSIBILITY TO CHECK WITH YOUR INSURANCE CARRIER TO MAKE SURE YOUR VISIT WILL BE COVERED
Appointment Date: Appointment Time: Patient: Welcome to The Pain Management Center with services provided by American Health Network. Please keep this information and let it serve as a reminder for your
ARTIC PC. Diagnosis & treatment study Diary. Version 1 ( )
Patient Study Number: Date of consultation: Month Year ARTIC PC Diagnosis & treatment study Diary Version 1 (09.08.16) Page 1 of 29 INSTRUCTIONS Your doctor or nurse and researchers from the ARTIC-PC study
A Cancer Patient s Guide to Radiation Therapy
RADIATION THERAPY A Cancer Patient s Guide to Radiation Therapy In this booklet you will learn about: What is radiation therapy The different stages in your treatment What happens during each stage Managing
Your Name: Date of Birth: Age: Address: City/State/Zip: Phone (home): (mobile): (work): Shall we add you to our e-newsletter?
Your Name: Date of Birth: Age: Address: City/State/Zip: _ Phone (home): (mobile): (work): Email: Shall we add you to our e-newsletter? Y / N Your Employer: Employer Phone: Employer Address: Your Occupation:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Pazopanib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Guide to Understanding Lung Cancer
Guide to Understanding Lung Cancer Lung cancer is the second most common cancer overall for men and women in the U.S., with an estimated 222,500 new cases in 2017. However, lung cancer is the most common
Wilms Tumour A brief note for the parents
Wilms Tumour A brief note for the parents By Dr. Abid Qazi!1 PARENT S GUIDE FACTSHEET Cancer is not an incurable disease any more in many circumstances. The key for cure is early diagnosis. However, it
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-EC PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Cancer and Advance Care Planning You ve been diagnosed with cancer. Now what?
Cancer and Advance Care Planning You ve been diagnosed with cancer. Now what? ACP Cancer Booklet-- Patient_FINAL.indd 1 You have a lot to think about and it can be difficult to know where to start. One
Surgery. In this fact sheet. Surgery: English
Surgery: English Surgery This information is about surgery (having an operation). Any words that are underlined are explained in the glossary at the end. Many people with cancer will have surgery as part
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Dabrafenib-Trametinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
National Cancer Action Team. Rehabilitation Care Pathway Brain CNS
National Cancer Action Team Rehabilitation Care Pathway Brain CNS Rehabilitation Care Pathway Brain CNS Diagnosis & Care Planning Drop Down Pathways Dysphagia Mobility/ loss of function Intervention D1
Information for Patients Receiving Radiation Therapy: External Beam Treatment for Prostate Cancer
Patient & Family Guide 2018 Information for Patients Receiving Radiation Therapy: External Beam Treatment for Prostate Cancer www.nscancercare.ca Information for Patients Receiving Radiation Therapy: External
UW MEDICINE PATIENT EDUCATION. Baby Blues and More. Knowing About This in Advance Can Help
UW MEDICINE PATIENT EDUCATION Baby Blues and More Recognizing and coping with postpartum mood disorders Some women have baby blues or more serious postpartum mood disorders. It helps to know about these
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-Oxaliplatin- Fluorouracil (FLOT) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Sunitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
patient decision aid advanced lung cancer
patient decision aid advanced lung cancer Introduction This aid is meant to supplement conversations with your care team. Patients who have used a decision aid like this said it helped them make care choices
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: FEC-P PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP: MALE
PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth
Page 1 of 6 FORM FERRERI / IELSG PROTOCOL Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS
Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.
Cisplatin & Mitomycin C Cisplatin & Mitomycin C This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
Myeloma Haematology and Transplant Unit MPT
MPT Myeloma Haematology and Transplant Unit MPT This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
Oral Etoposide (Lymphoma)
Oral Etoposide (Lymphoma) Oral Etoposide (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS Patient s surname/family name Patient s first names Date of birth Hospital
National Cancer Survivorship Initiative. Ciarán Devane Chief Executive Macmillan Cancer Support
National Cancer Survivorship Initiative Ciarán Devane Chief Executive Macmillan Cancer Support The National Cancer Survivorship Initiative (NCSI) will consider a range of approaches to survivorship care
MY TRACKING DIARY. MY Tracking. Diary TAKING ACTION AGAINST EPILEPSY
MY TRACKING DIARY MY Tracking Diary TAKING ACTION AGAINST EPILEPSY CONTACT INFORMATION PERSONAL Name: Phone: Email: MAIN CAREGIVER/COMPANION Name: Phone: Email: FAMILY PHYSICIAN Name: Phone: Email: TABLE
ADJUVANT CHEMOTHERAPY...
Colorectal Pathway Board: Non-Surgical Oncology Guidelines October 2015 Organization» Table of Contents ADJUVANT CHEMOTHERAPY... 2 DUKES C/ TNM STAGE 3... 2 DUKES B/ TNM STAGE 2... 3 LOCALLY ADVANCED
Temozolomide Chemotherapy -
n The Leeds Teaching Hospitals NHS Trust Temozolomide Chemotherapy - instructions for taking during your radiotherapy for a primary brain tumour Information for patients This information is for patients
Living with CLL. Results from the quality of life survey among CLLSA members. September 2014
Living with CLL Results from the quality of life survey among CLLSA members September 2 Contents Overview Executive summary Who completed the survey Reported QoL impact for pre-treatment watch and wait
Urology Clinical Forum. 23 rd September 2015
Urology Clinical Forum 23 rd September 2015 Welcome and Introductions Justin Vale, Chair of the LCA Urology Pathway Group Progress of the Urology Pathway Group Justin Vale, Chair of the LCA Urology Pathway
Help with costs. easy read. when you have cancer
Help with costs easy read when you have cancer About this easy read booklet This information is about help with money when you have cancer. You will learn about help with costs such as: travel to hospital
Helping you understand the care and support you can ask for in Wales.
Helping you understand the care and support you can ask for in Wales. Contents About this leaflet What type of support can I ask for? What type of information can I ask for? What questions can I ask my
The treatment is given every 3 weeks for 6 to 8 cycles.
R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it
Pain Clinic Packet Neal E. Coleman, MD Andrew Trobridge, MD Angelia Huffmeyer, FNP J. Mark Hannaford, PA Matthew Stinson, PA-C
Appointment Date: Appointment Time: Patient: Welcome to The Pain Management Center with services provided by American Health Network. Please keep this information and let it serve as a reminder for your
Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL
Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL Patient s surname/family name Patient s first names Date of birth